Mirae Asset Global ETFs Holdings’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Mirae Asset Global ETFs Holdings's CDNA Position: Q2 2026 in Review
Mirae Asset Global ETFs Holdings increased its CareDx (CDNA) stake by 22% in Q2 2026, buying an estimated $305K and bringing the position to 76,682 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1194.
Mirae Asset Global ETFs Holdings first reported a position in CDNA in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.35M in Q3 2024. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Mirae Asset Global ETFs Holdings held 76,682 shares of CareDx worth $2.19M as of Q2 2026.
- Mirae Asset Global ETFs Holdings bought 14,009 CareDx shares in Q2 2026, an estimated $305K.
- CareDx made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1194 holding.
- Mirae Asset Global ETFs Holdings first reported a position in CareDx in Q2 2024 and has held it in 9 quarters since.
- Mirae Asset Global ETFs Holdings's CareDx position peaked at $3.35M in Q3 2024.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.